Getinge B, SE0000202624

Pareto downgrades Getinge and keeps Getinge stock target at SEK 255.00

Published on 09/30/2026 at 16:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales rose 4.60 percent and adjusted EBITA margin reached 17.60 percent. Getinge stock trades at EUR 21.86 on September 30, 2026, versus EUR 21.86.

Aquarell der Göteborger Uferpromenade mit Hochhäusern und Hafenkränen — Getinge AB (ISIN SE0000202624) präsentiert die Hafenstadt Göteborg als sanftes Aquarellgemälde mit Bürogebäuden und Kränen, Illustration mit AI erstellt.

Getinge B (ISIN SE0000202624) was trading at EUR 21.86 at Lang & Schwarz on September 30, 2026, unchanged versus the prior close of EUR 21.86 on September 29, 2026. The latest analyst signal came on September 24, 2026, when MarketScreener reported that Pareto Securities downgraded the shares from Buy to Hold while reiterating a SEK 255.00 price target.

Pareto keeps SEK 255 target

The rating change places more weight on valuation after a strong recovery in the shares. Pareto kept its target at SEK 255.00, while MarketScreener reported on September 7, 2026, that ABG Sundal Collier raised its target from SEK 225.00 to SEK 285.00 and upgraded Getinge from Hold to Buy.

The two views show the debate around Getinge clearly: operational improvement is progressing, but the latest target changes are not uniform. MarketScreener listed 11 analysts in its consensus and an average target of SEK 250.20 in the September 24 update.

Second-quarter margins improved

Getinge's second-quarter operating picture was stronger than the flat intraday euro quote suggests. According to the Yahoo Finance transcript, organic sales grew 4.60 percent in the quarter and order intake increased 6.20 percent. Adjusted EBITA reached SEK 1.478 billion, equivalent to a 17.60 percent margin.

The same transcript shows a sharp sequential improvement in the reported operating result. Finance data put second-quarter revenue at SEK 8.381 billion and net income at SEK 841.00 million, compared with first-quarter revenue of SEK 7.443 billion and net income of SEK 401.00 million.

Guidance holds at 3 to 5 percent

Management reiterated 2026 organic net sales growth guidance of 3.00 percent to 5.00 percent, adjusted for the phaseout of Surgical Perfusion, according to the Yahoo Finance transcript. The company also continues to target a 2028 adjusted EBITDA margin of 16.00 percent to 19.00 percent.

The main counterweight is uneven regional demand. A September 15, 2026 report from Investing.com described 9.00 percent organic EMEA sales growth in the second quarter, while China remained a weaker market and labor inflation continued to pressure costs.

Getinge stock holds its level

Getinge stock was trading at EUR 21.86 at Lang & Schwarz on September 30, 2026 at 4:43 p.m. CEST, with a zero percent change versus the prior close of EUR 21.86. On Nasdaq Stockholm, the finance quote showed SEK 248.20 at 4:57 p.m. CEST, a 52-week range of SEK 175.90 to SEK 251.40 and market capitalization of SEK 67.6 billion.